ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5) Peptide
ST3GAL5
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
-
- Target See all ST3GAL5 products
- ST3GAL5 (ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- DSEAESKYDP PFGFRKFSSK VQTLLELLPE HDLPEHLKAK TCRRCVVIGS
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ST3 GAL5 antibody,
Alternative Names: ST3GAL5 control peptide, ST3GAL5 antibody Blocking Peptide, Anti-ST3GAL5 Blocking Peptide, St3 Beta-Galactoside Alpha-23-Sialyltransferase 5 Blocking Peptide, SIAT9 Blocking Peptide, SIATGM3S Blocking Peptide, ST3GalV Blocking Peptide, ST3GAL5, STGAL5-3, STGAL5 3, STGAL5-3 Blocking Peptide, STGAL5 3 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- ST3GAL5 (ST3 beta-Galactoside alpha-2,3-Sialyltransferase 5 (ST3GAL5))
- Background
- Ganglioside GM3 is known to participate in the induction of cell differentiation, modulation of cell proliferation, maintenance of fibroblast morphology, signal transduction, and integrin-mediated cell adhesion. ST3GAL5 is a type II membrane protein which catalyzes the formation of GM3 using lactosylceramide as the substrate. It is a member of glycosyltransferase family 29 and may be localized to the Golgi apparatus. Mutation in its gene has been associated with Amish infantile epilepsy syndrome.
- Molecular Weight
- 48 kDa
-
You are here:
